IRCT20111119008129N12RecruitingPhase 3
The protective Potential of resveratrol in the prevention and reduction of complications in patients undergoing elective coronary artery bypass grafting surgery
Boushehr University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 30 years to 70 years (—)
- Sex
- All
Inclusion Criteria
- •Intention of the patients to participate in the trial
- •Patients on elective surgery
- •Having no addiction to any drugs or alcohol
- •Not having mental or psychological disorders
- •Participants with the age between 30 to 70 years
Exclusion Criteria
- •History of having chronic kidney disease,
- •History of having chronic liver disease
- •Having heart surgery before
Investigators
Similar Trials
Recruiting
Phase 3
Resveratrol in COVID19IRCT20200112046089N1Ahvaz University of Medical Sciences50
Completed
Phase 3
Investigating the effect of resveratrol on polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovary syndromeE28.2IRCT20221106056417N1Tehran University of Medical Sciences56
Recruiting
Phase 3
The effect of Resveratrol on some biochemical and hormonal factorsMetabolic syndrome.IRCT20200408046987N4Qazvin University of Medical Sciences80
Completed
Phase 3
Evaluation of the effects of resveratrol in patients with Covid ??Covid-19.COVID-19, virus identifiedIRCT20111119008129N13Boushehr University of Medical Sciences140
Completed
Not Applicable
The effects of Resveratrol on PCOS.Polycystic ovarian syndrome (PCOS).Polycystic ovarian syndromeIRCT2016030126860N1Tehran University of Medical Sciences40